Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)

• Status: Completed
• Trial end date: 2014-07-01

Summary

This is a study of safety and effectiveness of ceftaroline fosamil in children with Community Acquired Bacterial Pneumonia receiving antibiotic therapy in the hospital.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: Forest Laboratories
• Collaborator: AstraZeneca
• Treatments: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ceftaroline fosamil; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids